Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraden

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Pharmaceutical Medicine|May 5, 2024
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in NigeriaUchenna Geraldine Elemuwa, Fraden Bitrus, Ibrahim Adekunle Oreagba, et al.
Journal of the American Chemical Society|September 10, 2024
Cell-Free Nonequilibrium Assembly for Hierarchical Protein/Peptide NanopillarsJiaqi Guo, Ayisha Zia, Qianfeng Qiu, et al.
Vaccine|March 12, 2025
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021Omotayo Bolu, Oluwafemi D Alo, Emem Iwara, et al.
Scientific Reports|July 29, 2025
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trialAbideen Salako, Adesola Musa, Fehintola Ige, et al.
Scientific Reports|August 20, 2025
Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trialAbideen Salako, Adesola Musa, Fehintola Ige, et al.
Trials|December 16, 2025
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trialAdesola Zaidat Musa, Abideen Olurotimi Salako, James Babatunde Ayorinde, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Pharmaceutical Medicine|May 5, 2024
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in NigeriaUchenna Geraldine Elemuwa, Fraden Bitrus, Ibrahim Adekunle Oreagba, et al.
Journal of the American Chemical Society|September 10, 2024
Cell-Free Nonequilibrium Assembly for Hierarchical Protein/Peptide NanopillarsJiaqi Guo, Ayisha Zia, Qianfeng Qiu, et al.
Vaccine|March 12, 2025
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021Omotayo Bolu, Oluwafemi D Alo, Emem Iwara, et al.
Scientific Reports|July 29, 2025
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trialAbideen Salako, Adesola Musa, Fehintola Ige, et al.
Scientific Reports|August 20, 2025
Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trialAbideen Salako, Adesola Musa, Fehintola Ige, et al.
Trials|December 16, 2025
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trialAdesola Zaidat Musa, Abideen Olurotimi Salako, James Babatunde Ayorinde, et al.
Pageof 10